Perseus Proteomics Inc. (TYO:4882)
Japan · Delayed Price · Currency is JPY 255.00
+1.00 (0.39%)
Jan 22, 2026, 3:30 PM JST
Perseus Proteomics Revenue
Perseus Proteomics had revenue of 36.53M JPY in the quarter ending September 30, 2025, a decrease of -6.34%. This brings the company's revenue in the last twelve months to 121.00M, up 11.01% year-over-year. In the fiscal year ending March 31, 2025, Perseus Proteomics had annual revenue of 120.00M with 20.00% growth.
Revenue (ttm)
121.00M
Revenue Growth
+11.01%
P/S Ratio
30.96
Revenue / Employee
3.78M
Employees
32
Market Cap
3.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 120.00M | 20.00M | 20.00% |
| Mar 31, 2024 | 100.00M | 6.00M | 6.38% |
| Mar 31, 2023 | 94.00M | 23.00M | 32.39% |
| Mar 31, 2022 | 71.00M | 4.00M | 5.97% |
| Mar 31, 2021 | 67.00M | -18.00M | -21.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |